Standard chemotherapy for gastric carcinoma: Is it a myth?

被引：3

作者：

Tebbutt, NC ^{[1
]}

Norman, A ^{[1
]}

Hill, M ^{[1
]}

Cunningham, D ^{[1
]}

机构：

[1] Royal Marsden Hosp, Sutton, Surrey, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 10期

关键词：

D O I：

10.1200/JCO.2001.19.10.2765

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2765 / 2766

页数：2

共 6 条

[1] Standard chemotherapy for gastric carcinoma: Is it a myth? [J].

Ajani, JA .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :4001-4002

[2] FAMTX VERSUS ETOPOSIDE, DOXORUBICIN, AND CISPLATIN - A RANDOM ASSIGNMENT TRIAL IN GASTRIC-CANCER [J].

KELSEN, D ;

ATIQ, OT ;

SALTZ, L ;

NIEDZWIECKI, D ;

GINN, D ;

CHAPMAN, D ;

HEELAN, R ;

LIGHTDALE, C ;

VINCIGUERRA, V ;

BRENNAN, M .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :541-548

[3]

Ross P, 1999, P AN M AM SOC CLIN, V18, p272a

[4] Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European organization for research and treatment of cancer gastrointestinal tract cancer cooperative group [J].

Vanhoefer, U ;

Rougier, P ;

Wilke, H ;

Ducreux, MP ;

Lacave, AJ ;

Van Cutsem, E ;

Planker, M ;

Dos Santos, JG ;

Piedbois, P ;

Paillot, B ;

Bodenstein, H ;

Schmoll, HJ ;

Bleiberg, H ;

Nordlinger, B ;

Couvreur, ML ;

Baron, B ;

Wils, JA .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2648-2657

[5] Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer [J].

Webb, A ;

Cunningham, D ;

Scarffe, JH ;

Harper, P ;

Norman, A ;

Joffe, JK ;

Hughes, M ;

Mansi, J ;

Findlay, M ;

Hill, A ;

Oates, J ;

Nicolson, M ;

Hickish, T ;

OBrien, M ;

Iveson, T ;

Watson, M ;

Underhill, C ;

Wardley, A ;

Meehan, M .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :261-267

[6] SEQUENTIAL HIGH-DOSE METHOTREXATE AND FLUOROURACIL COMBINED WITH DOXORUBICIN - A STEP AHEAD IN THE TREATMENT OF ADVANCED GASTRIC-CANCER - A TRIAL OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER GASTROINTESTINAL-TRACT COOPERATIVE GROUP [J].

WILS, JA ;

KLEIN, HO ;

WAGENER, DJT ;

BLEIBERG, H ;

REIS, H ;

KORSTEN, F ;

CONROY, T ;

FICKERS, M ;

LEYVRAZ, S ;

BUYSE, M ;

DUEZ, N .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) :827-831

← 1 →